AstraZeneca-Ionis drug fails to meet main goal in late-stage heart disease trial

AstraZeneca-Ionis drug fails to meet main goal in late-stage heart disease trial  Reuters

Summary aggregated from Reuters's public RSS feed. The full reporting belongs to Reuters — please read it on their site.